Adderall XR: long acting stimulant for single daily dosing

References

• Faraone SV, Spencer TJ, Montano CB, Biederman J. Attention deficit hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch. Intern. Med. 164,1221–1226 (2004).
   PubMed Web of Science ®Google Scholar
• Pediatrics AAO. Clinical Practice Guideline: treatment of the school-aged child with attention deficit hyperactivity disorder. Pediatrics 108,1033–1044 (2000).
   Web of Science ®Google Scholar
• Brown RT, Freeman WS, Perrin JM et al. Prevalence and assessment of attention deficit hyperactivity disorder in primary care settings. Pediatrics 107, E43 (2001).
   PubMed Web of Science ®Google Scholar
• Barkley RA. Attention deficit hyperactivity disorder. Sci. Am. 279,66–71 (1998).
   PubMed Web of Science ®Google Scholar
• Zarin DA, Tanielian TL, Suarez AP, Marcus SC. Treatment of attention deficit hyperactivity disorder by different physician specialties. Psych/an: Serv 49,171 (1998).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J. Attention deficit hyperactivity disorder in adults. JAMA 292,619–623 (2004).
   Google Scholar
• Greenhill BBO. Rita/in: Theory and Practice. Second Edition. Mary Ann Liebert Inc., NY, USA (2000).
   Google Scholar
• Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am.j Psychiatry 160,1909–1918 (2003).
   PubMed Web of Science ®Google Scholar
• Grcevich S. 5LI381: a long-acting psychostimulant preparation for the treatment of attention deficit hyperactivity disorder. Expert Opin. Investig. Drugs 10, 2003-2011 (2001).
   Google Scholar
• Pliszka SR, Greenhill LL, Crisman ML et al. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention Deficit Hyperactivity Disorder. Part II: Tactics. Attention deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry39, 920–927 (2000).
   Google Scholar
• Hardman JG. Goodman & Gilman's The Pharmacological Basis of Therapeutics. TenthEdition. McGraw-Hill, OH, USA (2001).
   Google Scholar
• Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit hyperactivity disorder: a review and integration. Behav. Brain. Res. 94,127–152 (1998).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, McCracken JT, Maas JVV. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. Arn. Acad. Child Adolesc. Psychiatry35, 264–272 (1996).
   Google Scholar
• Arnold LE, Wender PH, McCloskey K, Snyder SH. Levoamphetamine and dextroamphetamine: comparative efficacy in the hyperkinetic syndrome. Assessment by target symptoms. Arch. Gem Psychiatry 27,816–822 (1972).
   PubMed Web of Science ®Google Scholar
• Arnold LE, Huestis RD, Smeltzer DJ, Scheib J, Wemmer D, Colner G. Levoamphetamine versus dextroamphetamine in minimal brain dysfunction. Replication, time response, and differential effect by diagnostic group and family rating. Arch. Gem Psychiatry 33, 292–301 (1976).
   Google Scholar
• Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention deficit hyperactivity disorder. Clin. Pharmacokinet. 40,753–772 (2001).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wigal S, Greenhill LL et al. Analog classroom assessment of Adderall in children with ADHD. j Am. Acad. Child. Adolesc. Psychiatry 37,519–526 (1998).
   PubMed Web of Science ®Google Scholar
• McCracken JT, Biederman J, Greenhill LL et al. Analog classroom assessment of a once-daily mixed amphetamine formulation, 5L1381 (Adderall XR), in children with ADHD. j Am. Acad. Child. Adolesc. Psychiatry 42,673–683 (2003).
   Google Scholar
• ••Established the duration of Adderall XReffect as 12 h.
   Google Scholar
• McGough JJ, McCracken JT. Assessment of attention deficit hyperactivity disorder: a review of recent literature. CUIT: Opin. Pediatr. 12,319–324 (2000).
   Web of Science ®Google Scholar
• Tulloch SJ, Zhang Y, McLean A, Wolf KN. SL1381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed and sprinkled administration. Pharmacotherapy22, 1405–1415 (2002).
   PubMed Web of Science ®Google Scholar
• Tulloch S, Frazer N, Kisicki J, Clausen S, Yu K. Dose proportionality of 20,40, and 60 mg of an extended-release formulation of mixed amphetamine salts in adults. 43rdAnnual National Clinical Drug Evaluation, FL, USA (2003).
   Google Scholar
• Boellner SW, Tulloch SJ, Zhang Y. A single- dose bioequivalence study comparing 1 X 30 mg capsule of 5L1381 to 3 X 10 mg capsules of SL1381 in pediatric subjects. NCDEU 41 Annual Meeting, AZ, USA (2001).
   Google Scholar
• McGough JJ, Biederman J, Greenhill LL et al. Pharmacokinetics of SL1381 (Adderall XR), an extended-release formulation of Adderall. j Am. Acad. Child. Adolesc. Psychiatry 42, 684–691 (2003).
   Google Scholar
• Biederman J, Lopez FA, Boellner SW, Chandler MC. A randomized, double-blind, placebo-controlled, parallel-group study of SL1381 (Adderall XR) in children with attention deficit hyperactivity disorder. Pediatrics 110, 258–266 (2002).
   PubMed Web of Science ®Google Scholar
• ••Definitive efficacy and safety report ofAdderall XR in children with attention deficit hyperactivity disorder.
   Google Scholar
• Wigal S, McGough JJ, McCracken JT. Analog classroom study of amphetamine extended release and atomoxetine in youth with ADHD. 157th Annual Meeting of American Psychiatric Association. NY, USA (2004).
   Google Scholar
• Sallee FR, Ambrosini PJ, Lopez FA. Health-related quality of life and treatment satisfaction and preference in the community. j Outcomes. Res. (2004) (In Press).
   Google Scholar
• Faraone S, Biederman J, Spencer T. Dose- response efficacy of mixed amphetamine salts XR in adults with ADHD. 157th Annual Meeting of American Psychiatric Association, NY, USA (2004).
   Google Scholar
• Weisler J B, Chrisman AK, Wilens T S, Tulloch S. Long-term safety and efficacy of once-daily Adderall XR in adults with ADHD. 16th Annual US Psychiatric and Mental Health Congress, FL, USA (2003).
   Google Scholar
• Spencer T, Biederman J, Abikoff H, Pliszka SR, Lopez FA. Safety and efficacy of mixed amphetamine salts extended release in children and adolescents with oppositional defiant disorder (ODD). 157th Annual Meeting of American Psychiatric Association, NY, USA (2004).
   Google Scholar
• Lopez FA, Mays DA, Shi L, Tulloch S. Tolerability of Adderall XR in girls with attention deficit hyperactivity disorder. 16th Annual US Psychiatric and Mental Health Congress, FL, USA (2003).
   Google Scholar
• Biederman Si', Faraone S. Extended-release mixed amphetamine salts in ADHD: growth parameter analysis. American Psychiatric Association Annual Meeting, CA, USA (2003).
   Google Scholar
• Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and adderall. j Am. Acad. Child Adolesc. Psychiatry 40,525–529 (2001).
   PubMed Web of Science ®Google Scholar
• Ambrosini LF, Chandler MC. An open-label community assesment trial of Adderall XR in pediatric ADHD. American Psychiatric Association Annual Meeting, CA, USA (2003).
   Google Scholar
• Chandler LF, Biederman J. Long-term Adderall XR treatment improves quality of life in ADHD children. American Psychiatric Association Annual Meeting, CA, USA (2003).
   Google Scholar
• Thomas S, Upadhyaya H. Adderall and seizures. j Am. Acad. Child. Adolesc. Psychiatry 41, 365 (2002).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Roe C. Comparative efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a meta-analysis. Clin. Psychopharmacol. 22,468-473 (2002).
   Google Scholar
• Swanson JM, Wigal SB, Wigal T etal. A comparison of once-daily extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113, 206–216 (2004).
   Google Scholar